Deal Making

Featured on Deal Making

Roche licenses cell line-based AAV vector tech from CEVEC
Deal-Making
Roche licenses cell line-based AAV vector tech from CEVECRoche licenses cell line-based AAV vector tech from CEVEC

Roche will access an adeno-associated virus (AAV) vector manufacturing platform in a deal CEVEC says validates its ELEVECTA technology.

byDan Stanton, Editorial director
Nov 24, 2020
|
2 Min Read
Samsung Bio in $150m deal to make COVID antibodies for Lilly
Facilities & Capacity
Samsung Bio in $150m deal to make COVID antibodies for LillySamsung Bio in $150m deal to make COVID antibodies for Lilly
byDan Stanton
Nov 23, 2020
2 Min Read
Altimmune partners with Lonza on intranasal COVID-19 vaccine
Deal-Making
Altimmune partners with Lonza on intranasal COVID-19 vaccineAltimmune partners with Lonza on intranasal COVID-19 vaccine
byBen Hargreaves
Nov 16, 2020
3 Min Read
Novo Nordisk in $1.8bn deal for oral biologic tech
Deal-Making
Novo Nordisk in $1.8bn deal for oral biologic techNovo Nordisk in $1.8bn deal for oral biologic tech
byBen Hargreaves
Nov 11, 2020
2 Min Read
CRISPR, reagents, cell lines: PerkinElmer buying Horizon Discovery
Deal-Making
CRISPR, reagents, cell lines: PerkinElmer buying Horizon DiscoveryCRISPR, reagents, cell lines: PerkinElmer buying Horizon Discovery
byGareth Macdonald
Nov 3, 2020
2 Min Read
Natural killer deal: Sanofi buying Kiadis for $358m
Deal-Making
Natural killer deal: Sanofi buying Kiadis for $358mNatural killer deal: Sanofi buying Kiadis for $358m
byBPI Staff
Nov 2, 2020
1 Min Read

More from Deal Making

Lonza to support AstraZeneca’s COVID-19 antibody combo
Deal-Making
Lonza to support AstraZeneca’s COVID-19 antibody combo
Lonza to support AstraZeneca’s COVID-19 antibody combo
Oct 30, 2020
|
1 Min Read
byDan Stanton, Editorial director
Catalent bones up on CGTs with Skeletal Cell Therapy buy
Deal-Making
Catalent bones up on CGTs with Skeletal Cell Therapy buy
Catalent bones up on CGTs with Skeletal Cell Therapy buy
Oct 29, 2020
|
2 Min Read
byGareth Macdonald
Amyris and IDRI agree RNA vaccine platform deal
Therapeutic Class
Amyris and IDRI agree RNA vaccine platform deal
Amyris and IDRI agree RNA vaccine platform deal
Oct 29, 2020
|
3 Min Read
byBen Hargreaves
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
Deal-Making
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
Oct 28, 2020
|
2 Min Read
byDan Stanton, Editorial director
Bayer adds AAV-based gene therapy tech in $2bn AskBio buy
Deal-Making
Bayer adds AAV-based gene therapy tech in $2bn AskBio buy
Bayer adds AAV-based gene therapy tech in $2bn AskBio buy
Oct 26, 2020
|
2 Min Read
byDan Stanton, Editorial director
Roche enlists Dyno to bring AI to liver, CNS gene therapies
Deal-Making
Roche enlists Dyno to bring AI to liver, CNS gene therapies
Roche enlists Dyno to bring AI to liver, CNS gene therapies
Oct 20, 2020
|
5 Min Read
byFrank Vinluan
Vaxart ups production as oral COVID-19 vaccine dosing begins
Deal-Making
Vaxart ups production as oral COVID-19 vaccine dosing begins
Vaxart ups production as oral COVID-19 vaccine dosing begins
Oct 14, 2020
|
2 Min Read
byBen Hargreaves
Lilly hires Fujifilm Diosynth Biotechnologies to make COVID-19 mAbs
Facilities & Capacity
Lilly hires Fujifilm Diosynth Biotechnologies to make COVID-19 mAbs
Lilly hires Fujifilm Diosynth Biotechnologies to make COVID-19 mAbs
Oct 12, 2020
|
2 Min Read
byGareth Macdonald
Pfizer/BioNTech recruits Rentschler to support COVID-19 vaccine
Facilities & Capacity
Pfizer/BioNTech recruits Rentschler to support COVID-19 vaccine
Pfizer/BioNTech recruits Rentschler to support COVID-19 vaccine
Oct 9, 2020
|
2 Min Read
byDan Stanton, Editorial director
Fujifilm to use PNI tech to make nanoparticles for VLP’s COVID vaccine
Deal-Making
Fujifilm to use PNI tech to make nanoparticles for VLP’s COVID vaccine
Fujifilm to use PNI tech to make nanoparticles for VLP’s COVID vaccine
Oct 6, 2020
|
2 Min Read
byGareth Macdonald
Sartorius set to acquire BIA Separations for $423m
Upstream & Downstream Processing
Sartorius set to acquire BIA Separations for $423m
Sartorius set to acquire BIA Separations for $423m
Oct 5, 2020
|
2 Min Read
byGareth Macdonald
BMS to buy MyoKardia, adding heart disease drug for $13.1bn
Deal-Making
BMS to buy MyoKardia, adding heart disease drug for $13.1bn
BMS to buy MyoKardia, adding heart disease drug for $13.1bn
Oct 5, 2020
|
4 Min Read
byFrank Vinluan
Astrea continues acquisition path picking up purification firm Nanopareil
Upstream & Downstream Processing
Astrea continues acquisition path picking up purification firm Nanopareil
Astrea continues acquisition path picking up purification firm Nanopareil
Oct 5, 2020
|
3 Min Read
byDan Stanton, Editorial director
Orgenesis acquires cell therapy specialist Koligo for $15m
Deal-Making
Orgenesis acquires cell therapy specialist Koligo for $15m
Orgenesis acquires cell therapy specialist Koligo for $15m
Oct 2, 2020
|
3 Min Read
byBen Hargreaves
Novavax and J&J ink COVID-19 vaccine fill/finish deals
Facilities & Capacity
Novavax and J&J ink COVID-19 vaccine fill/finish deals
Novavax and J&J ink COVID-19 vaccine fill/finish deals
Sep 30, 2020
|
2 Min Read
byDan Stanton, Editorial director
Humanigen strikes third manufacturing deal for COVID-19 therapy
Deal-Making
Humanigen strikes third manufacturing deal for COVID-19 therapy
Humanigen strikes third manufacturing deal for COVID-19 therapy
Sep 25, 2020
|
3 Min Read
byBen Hargreaves
Pfizer to make Vivet’s Wilson disease gene therapy for Phase I/II trial
Deal-Making
Pfizer to make Vivet’s Wilson disease gene therapy for Phase I/II trial
Pfizer to make Vivet’s Wilson disease gene therapy for Phase I/II trial
Sep 24, 2020
|
2 Min Read
byGareth Macdonald
From flu jabs, to mAbs, to COVID collabs: BioNTech nabs Novartis plant and labs
Deal-Making
From flu jabs, to mAbs, to COVID collabs: BioNTech nabs Novartis plant and labs
From flu jabs, to mAbs, to COVID collabs: BioNTech nabs Novartis plant and labs
Sep 23, 2020
|
2 Min Read
byDan Stanton, Editorial director
Samsung Bio adds another Big Pharma customer with $331m AstraZeneca deal
Deal-Making
Samsung Bio adds another Big Pharma customer with $331m AstraZeneca deal
Samsung Bio adds another Big Pharma customer with $331m AstraZeneca deal
Sep 22, 2020
|
2 Min Read
byDan Stanton, Editorial director
Lilly turns to Amgen to up COVID-19 antibody production
Deal-Making
Lilly turns to Amgen to up COVID-19 antibody production
Lilly turns to Amgen to up COVID-19 antibody production
Sep 18, 2020
|
2 Min Read
byDan Stanton, Editorial director
Exelixis: Deals with NBE and Catalent bring multi-pronged ADC approach
Deal-Making
Exelixis: Deals with NBE and Catalent bring multi-pronged ADC approach
Exelixis: Deals with NBE and Catalent bring multi-pronged ADC approach
Sep 17, 2020
|
3 Min Read
byDan Stanton, Editorial director
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Deal-Making
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Gilead adds ‘cornerstone’ cancer drug in $21bn Immunomedics buyout
Sep 14, 2020
|
3 Min Read
byFrank Vinluan
Thermo-stability could give DNA vaccine advantage in COVID-19 race, says Inovio
Therapeutic Class
Thermo-stability could give DNA vaccine advantage in COVID-19 race, says Inovio
Thermo-stability could give DNA vaccine advantage in COVID-19 race, says Inovio
Sep 8, 2020
|
3 Min Read
byDan Stanton, Editorial director
Bridgewest gains CDMO biz through Pfizer pegfilgrastim plant buy
Deal-Making
Bridgewest gains CDMO biz through Pfizer pegfilgrastim plant buy
Bridgewest gains CDMO biz through Pfizer pegfilgrastim plant buy
Sep 8, 2020
|
2 Min Read
byDan Stanton, Editorial director
VMIC to help Oxford Biomedica up capacity for AstraZeneca AZD1222 deal
Deal-Making
VMIC to help Oxford Biomedica up capacity for AstraZeneca AZD1222 deal
VMIC to help Oxford Biomedica up capacity for AstraZeneca AZD1222 deal
Sep 7, 2020
|
2 Min Read
byGareth Macdonald
Adios AveXis: Novartis embeds $8.7bn acquisition into gene therapy rebrand
Deal-Making
Adios AveXis: Novartis embeds $8.7bn acquisition into gene therapy rebrand
Adios AveXis: Novartis embeds $8.7bn acquisition into gene therapy rebrand
Sep 4, 2020
|
2 Min Read
byDan Stanton, Editorial director
Astrea buys filtration firm ELS and hints at more acquisitions
Upstream & Downstream Processing
Astrea buys filtration firm ELS and hints at more acquisitions
Astrea buys filtration firm ELS and hints at more acquisitions
Sep 2, 2020
|
2 Min Read
byDan Stanton, Editorial director
Cryoport strikes second acquisition in a week with $320m MVE buy
Deal-Making
Cryoport strikes second acquisition in a week with $320m MVE buy
Cryoport strikes second acquisition in a week with $320m MVE buy
Aug 27, 2020
|
2 Min Read
byDan Stanton, Editorial director
CDMO deals and investments from AGC, Avid, and Fujifilm
Facilities & Capacity
CDMO deals and investments from AGC, Avid, and Fujifilm
CDMO deals and investments from AGC, Avid, and Fujifilm
Aug 21, 2020
|
3 Min Read
byDan Stanton, Editorial director
Charles River boosts cell therapy offering with $38m Cellero buy
Deal-Making
Charles River boosts cell therapy offering with $38m Cellero buy
Charles River boosts cell therapy offering with $38m Cellero buy
Aug 19, 2020
|
2 Min Read
byDan Stanton, Editorial director

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe